SRPT logo

Sarepta Therapeutics (SRPT)

Profile

Full Name

Sarepta Therapeutics, Inc.

Ticker Symbol

SRPT

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

June 4, 1997

Indexes

Not included

Website

http://www.sarepta.com

Employees

1372

Key Details

Price

$37.65(-19.47%)

Market cap

$3.65B(Mid cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$1.90B(+52.97% YoY)

Annual EPS

$2.34(+140.34% YoY)

PE ratio

16.51

Next earnings date

Aug 7, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$37.65
SRPT price is $37.65

30-Day Relative Volume

4.70
SRPT 30-day relative volume is 4.70

Price Performance

Price Today change

-19.47%
SRPT price is down -19.47% today

Price YTD change

-69.04%
SRPT price is down -69.04% since January 1st

Price 1-year change

-72.32%
SRPT price is down -72.32% year-on-year

Price 3-year change

-46.34%
SRPT price is down -46.34% over the past 3 years

Price Range

Price All-time high

$181.83
SRPT price is currently -79.29% below its historical high of $181.83

Price 3-year low

$36.90
SRPT price is currently +2.03% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$3.65B
SRPT market capitalization is $3.65 billion

Market cap 3-year change

-40.49%
SRPT market capitalization is down -40.49% over the past 3 years

Market cap All-time high

$15.60B
SRPT market capitalization is currently -76.57% below its historical high of $15.60 billion

Market cap sector rank

87.85%
SRPT market capitalization is higher than 87.85% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+2.65%
SRPT shares outstanding is up +2.65% year-on-year

Shares Outstanding 3-Year Change

+10.89%
SRPT shares outstanding is up +10.89% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.11
SRPT beta is 1.11

200-day SMA

$112.37
SRPT price is currently -66.50% below its 200-day simple moving average

50-day SMA

$74.03
SRPT price is currently -49.14% below its 50-day simple moving average

RSI

28.96
SRPT 14-day relative strength index is 28.96

Volume

4.70
SRPT 30-day relative volume is 4.70

ATR

$4.97
SRPT average true range is $4.97

10-day Historical Volatility

139.99%
SRPT 10-day historical volatility is 139.99%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$1.90B
SRPT annual revenue is $1.90 billion

Revenue Analysts estimate

$3.05B
SRPT annual revenue is currently -37.69% lower than the consensus analysts' forecast

Revenue 1-year change

+52.97%
SRPT annual revenue is up +52.97% year-on-year

Revenue Sector rank

84.48%
SRPT annual revenue is higher than 84.48% of companies in Healthcare sector

EPS

EPS

$2.34
SRPT annual earnings per share is $2.34

EPS Analysts estimate

$7.60
SRPT annual earnings per share is currently -69.21% lower than the consensus analysts' forecast

EPS 1-year change

+140.34%
SRPT annual earnings per share is up +140.34% year-on-year

EPS Sector rank

93%
SRPT annual earnings per share is higher than 93% of companies in Healthcare sector

Profit

Gross profit

$1.58B
SRPT annual gross profit is $1.58 billion

Gross margin

83.22%
SRPT annual gross profit margin is 83.22%

Operating profit

$218.08M
SRPT annual operating income is $218.08 million

Operating margin

11.47%
SRPT annual operating profit margin is 11.47%

Net income

$235.24M
SRPT annual net profit is $235.24 million

Net margin

12.37%
SRPT annual net profit margin is 12.37%

Expenses

Total expenses

$1.68B
SRPT annual total expenses is $1.68 billion

Operating expenses

$1.36B
SRPT annual total operating expenses is $1.36 billion

Cost of goods sold

$319.10M
SRPT annual cost of goods sold is $319.10 million

Selling, general & administrative expenses

$557.87M
SRPT annual SGA is $557.87 million

Depreciation and amortization

$37.72M
SRPT annual depreciation & amortization is $37.72 million

Interest expense

$18.39M
SRPT annual interest expense is $18.39 million

Income tax

$25.54M
SRPT annual income tax is $25.54 million

EBIT & EBITDA

EBIT

$279.17M
SRPT annual earnings before interest & taxes is $279.17 million

EBITDA

$316.89M
SRPT annual EBITDA is $316.89 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$3.96B
SRPT annual total assets is $3.96 billion

Non current assets

$889.71M
SRPT annual long term assets is $889.71 million

Current assets

$3.07B
SRPT annual total current assets is $3.07 billion

Cash and cash equivalents

$1.10B
SRPT annual cash & cash equivalents is $1.10 billion

Accounts receivable

$601.99M
SRPT annual accounts receivable is $601.99 million

Inventory

$749.96M
SRPT annual inventory is $749.96 million

Liabilities

Total liabilities

$2.44B
SRPT annual total liabilities is $2.44 billion

Long term liabilities

$1.70B
SRPT annual total long term liabilities is $1.70 billion

Current liabilities

$731.68M
SRPT annual total current liabilities is $731.68 million

Accounts payable

$214.44M
SRPT annual accounts payable is $214.44 million

Debt

Total debt

$1.34B
SRPT annual total debt is $1.34 billion

Total debt 1-year change

-3.85%
SRPT annual total debt is down -3.85% year-on-year

Long term debt

$1.33B
SRPT annual long term debt is $1.33 billion

Short term debt

$13.47M
SRPT annual short term debt is $13.47 million

Equity & Capital

Shareholders equity

$1.53B
SRPT annual stockholders equity is $1.53 billion

Book value

$1.53B
SRPT annual book value is $1.53 billion

Retained earnings

-$4.21B
SRPT annual retained earnings is -$4.21 billion

Working capital

$2.34B
SRPT annual working capital is $2.34 billion

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$205.79M
SRPT annual cash flow from operations is -$205.79 million

Cash from operations 1-year change

+58.92%
SRPT annual cash flow from operations is up +58.92% year-on-year

Cash from investing

$755.56M
SRPT annual cash flow from investing activities is $755.56 million

Cash from investing 1-year change

+555.7%
SRPT annual cash flow from investing activities is up +555.7% year-on-year

Cash from financing

$124.81M
SRPT annual cash flow from financing activities is $124.81 million

Cash from financing 1-year change

-0.16%
SRPT annual cash flow from financing activities is down -0.16% year-on-year

CAPEX

CAPEX

$146.96M
SRPT annual capital expenditures is $146.96 million

CAPEX 1-year change

+68.25%
SRPT annual capital expenditures is up +68.25% year-on-year

Free Cash Flow

Free cash flow

-$352.74M
SRPT annual free cash flow is -$352.74 million

Free cash flow 1-year change

+40.04%
SRPT annual free cash flow is up +40.04% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

83.22%
SRPT annual gross profit margin is 83.22%

Operating margin

11.47%
SRPT annual operating profit margin is 11.47%

Net margin

12.37%
SRPT annual net profit margin is 12.37%

ROA & ROE

ROA

6.51%
SRPT annual return on assets is 6.51%

ROE

19.71%
SRPT annual return on equity is 19.71%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

16.51
SRPT price to earnings ratio is 16.51

PE ratio Sector rank

31.53%
SRPT price to earnings ratio is higher than 31.53% of companies in Healthcare sector

PB Ratio

PB ratio

2.39
SRPT price to book ratio is 2.39

PB ratio Sector rank

65.85%
SRPT price to book ratio is higher than 65.85% of companies in Healthcare sector

PS Ratio

PS ratio

1.92
SRPT price to sales ratio is 1.92

PS ratio Sector rank

41.01%
SRPT price to sales ratio is higher than 41.01% of companies in Healthcare sector

Enterprise value

Enterprise value

$3.89B
SRPT enterprise value is $3.89 billion

Enterprise value Sector rank

87.08%
SRPT enterprise value is higher than 87.08% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

12.29
SRPT EV/EBITDA is 12.29

EV/EBITDA Sector rank

86.1%
SRPT EV/EBITDA is higher than 86.1% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

4.20
SRPT annual current ratio is 4.20

Quick ratio

3.18
SRPT annual quick ratio is 3.18

Leverage

Debt to equity

0.74
SRPT annual debt to equity ratio is 0.74

Interest coverage ratio

15.18
SRPT annual interest coverage ratio is 15.18

Risk & Stability

Piotroski F-Score

4
SRPT piotroski f-score is 4

Altman Z-Score

0.83
SRPT altman z-score is 0.83

Analyst ratings

Recent major analysts updates

Apr 21, 25 Piper Sandler
Overweight
Apr 16, 25 HC Wainwright & Co.
Neutral
Apr 11, 25 Wells Fargo
Overweight
Apr 11, 25 Morgan Stanley
Overweight
Apr 7, 25 HC Wainwright & Co.
Neutral
Apr 4, 25 HC Wainwright & Co.
Neutral
Apr 3, 25 Needham
Buy
Apr 2, 25 HC Wainwright & Co.
Neutral
Mar 31, 25 RBC Capital
Sector Perform
Mar 20, 25 Scotiabank
Sector Perform

Institutional Ownership

Similar stocks

PRGO logo
Perrigo (PRGO)
SHC logo
Sotera Health (SHC)
SWTX logo
SpringWorks Therapeutics (SWTX)
SLNO logo
Soleno Therapeutics (SLNO)
PCVX logo
Vaxcyte (PCVX)
AKRO logo
Akero Therapeutics (AKRO)
CYTK logo
Cytokinetics Incorporated (CYTK)
BLCO logo
Bausch Lomb (BLCO)
BTSG logo
BrightSpring Health Services (BTSG)
  • What is the ticker symbol for Sarepta Therapeutics?
  • Does Sarepta Therapeutics pay dividends?
  • What sector is Sarepta Therapeutics in?
  • What industry is Sarepta Therapeutics in?
  • What country is Sarepta Therapeutics based in?
  • When did Sarepta Therapeutics go public?
  • Is Sarepta Therapeutics in the S&P 500?
  • Is Sarepta Therapeutics in the NASDAQ 100?
  • Is Sarepta Therapeutics in the Dow Jones?
  • When was Sarepta Therapeutics's last earnings report?
  • When does Sarepta Therapeutics report earnings?
  • Should I buy Sarepta Therapeutics stock now?

What is the ticker symbol for Sarepta Therapeutics?

The ticker symbol for Sarepta Therapeutics is NASDAQ:SRPT

Does Sarepta Therapeutics pay dividends?

No, Sarepta Therapeutics does not pay dividends

What sector is Sarepta Therapeutics in?

Sarepta Therapeutics is in the Healthcare sector

What industry is Sarepta Therapeutics in?

Sarepta Therapeutics is in the Biotechnology industry

What country is Sarepta Therapeutics based in?

Sarepta Therapeutics is headquartered in United States

When did Sarepta Therapeutics go public?

Sarepta Therapeutics's initial public offering (IPO) was on June 4, 1997

Is Sarepta Therapeutics in the S&P 500?

No, Sarepta Therapeutics is not included in the S&P 500 index

Is Sarepta Therapeutics in the NASDAQ 100?

No, Sarepta Therapeutics is not included in the NASDAQ 100 index

Is Sarepta Therapeutics in the Dow Jones?

No, Sarepta Therapeutics is not included in the Dow Jones index

When was Sarepta Therapeutics's last earnings report?

Sarepta Therapeutics's most recent earnings report was on May 6, 2025

When does Sarepta Therapeutics report earnings?

The next expected earnings date for Sarepta Therapeutics is Aug 7, 2025

Should I buy Sarepta Therapeutics stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page